Erratum to: Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration

Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 6

Abstract

The online version of the original article can be found at http://dx.doi.org/10.1208/s12248-015-9782-0.

Authors and Affiliations

Sanna Rosengren, Samuel S. Dychter, Marie A. Printz, Lei Huang, Richard I. Schiff, Hans-Peter Schwarz, John K. McVey, Fred H. Drake, Dan C. Maneval, Don A. Kennard, Gregory I. Frost, Barry J. Sugarman, Douglas B. Muchmore

Keywords

Related Articles

Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells

Of the thousands of proven carcinogens and toxic agents contained within a cigarette, nicotine, while being the addictive agent, is often viewed as the least harmful of these compounds. Nicotine is a lipophilic molecule...

Therapeutic Applications of Curcumin Nanoformulations

Curcumin (diferuloylmethane) is a bioactive and major phenolic component of turmeric derived from the rhizomes of curcuma longa linn. For centuries, curcumin has exhibited excellent therapeutic benefits in various diseas...

A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Transplantation

The SNP A6986G of the CYP3A5 gene (*3) results in a non-functional protein due to a splicing defect whereas the C3435T was associated with variable expression of the ABCB1 gene, due to protein instability. Part of the la...

Deposition of nanoparticles in the arterial vessel by porous balloon catheters: Localization by confocal laser scanning microscopy and transmission electron microscopy

Restenosis remains the major limitation of percutaneous transluminal angloplasty (PTA) and stenting in the treatment of patients with atherosclerotic disease. Catheter-based local delivery of pharmacologic agents offers...

Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors

Biological membranes normally restrict the passage of hydrophilic molecules. This impairs the use of a wide variety of drugs for biomedical applications. To overcome this problem, researchers have developed strategies th...

Download PDF file
  • EP ID EP681036
  • DOI  10.1208/s12248-015-9822-9
  • Views 42
  • Downloads 0

How To Cite

Sanna Rosengren, Samuel S. Dychter, Marie A. Printz, Lei Huang, Richard I. Schiff, Hans-Peter Schwarz, John K. McVey, Fred H. Drake, Dan C. Maneval, Don A. Kennard, Gregory I. Frost, Barry J. Sugarman, Douglas B. Muchmore (2015). Erratum to: Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration. The AAPS Journal, 17(6), -. https://europub.co.uk/articles/-A-681036